Clinical Trials
7 trialsNCT00326885 2018-10-17
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
Phase 2 Completed
NCT00464893 2013-12-04
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Neovii Biotech
Phase 2 Completed
NCT00563836 2012-10-03
Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
Neovii Biotech
Phase 2 Completed
NCT00822809 2012-10-03
CASIMAS
Neovii Biotech
Phase 3 Completed
NCT00377429 2012-07-19
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Neovii Biotech
Phase 2 Completed
NCT00836654 2009-02-05
Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group
Neovii Biotech
Phase 2/3 Completed
NCT00352833 2007-10-26
Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma
Neovii Biotech
Phase 2 Completed